Skip to main content

Table 3 Association between AIP and CAD

From: Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states

Variables

Coronary artery disease

Model 1

Model 2

Model 3

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

AIP

5.981 (2.628–13.608)

< 0.001

5.210 (2.257–12.027)

< 0.001

3.897 (1.489–10.198)

0.006

 I

Reference

 

Reference

 

Reference

 

 II

1.854 (1.123–3.059)

0.016

1.719 (1.014–2.913)

0.044

1.326 (0.722–2.435)

0.363

 III

2.920 (1.691–5.042)

< 0.001

2.599 (1.471–4.591)

0.001

2.046 (1.063–3.937)

0.032

 IV

3.506 (1.978–6.213)

< 0.001

3.218 (1.775–5.835)

< 0.001

2.425 (1.201–4.898)

0.014

P-trend

< 0.001

< 0.001

0.007

  1. Model 1: unadjusted
  2. Model 2: adjusted for age and sex
  3. Model 3: adjusted for age, sex, SBP, BMI, smoking status, drinking status, LDL-C, HbA1c, DM, hypertension, status of antihypertensive drugs, status of antidiabetic drugs, status of antilipidemic drugs, status of antiplatelet drugs
  4. AIP atherogenic index of plasma, CAD coronary artery disease, SBP systolic blood pressure, BMI body mass index, LDL-C low-density lipoprotein cholesterol, HbA1c glycosylated hemoglobin, DM diabetes mellitus